With up to a quarter of women suffering from low libido, it is predicted to be at least as successful as Viagra, with worldwide sales topping £2billion a year.
Like Viagra, which was originally designed to treat heart problems, flibanserin was formulated with another purpose in mind.
It was created as an anti-depressant but those taking part in trials said it did nothing to boost their mood but did wonders for their sex drive.
Too bad this Boehringer Ingelheim is not publicly traded or it will a stock to watch for sure. I would be all over an IPO or I could see Pfizer buying them out in order to create a total solution for men and women.
No comments:
Post a Comment